Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Population pharmacokinetics-pharmacodynamics of oral everolimus in patients with seizures associated with tuberous sclerosis complex.

Combes FP, Baneyx G, Coello N, Zhu P, Sallas W, Yin H, Nedelman J.

J Pharmacokinet Pharmacodyn. 2018 Jul 10. doi: 10.1007/s10928-018-9600-2. [Epub ahead of print]

PMID:
29992479
2.

Pazopanib Exposure Relationship with Clinical Efficacy and Safety in the Adjuvant Treatment of Advanced Renal Cell Carcinoma.

Sternberg CN, Donskov F, Haas NB, Doehn C, Russo P, Elmeliegy M, Baneyx G, Banerjee H, Aimone P, Motzer RJ.

Clin Cancer Res. 2018 Jul 1;24(13):3005-3013. doi: 10.1158/1078-0432.CCR-17-2652. Epub 2018 Jan 12.

PMID:
29330204
3.

Physiologically based pharmacokinetic modeling of CYP3A4 induction by rifampicin in human: influence of time between substrate and inducer administration.

Baneyx G, Parrott N, Meille C, Iliadis A, Lavé T.

Eur J Pharm Sci. 2014 Jun 2;56:1-15. doi: 10.1016/j.ejps.2014.02.002. Epub 2014 Feb 12.

PMID:
24530864
4.

Proof of principle for epitope-focused vaccine design.

Correia BE, Bates JT, Loomis RJ, Baneyx G, Carrico C, Jardine JG, Rupert P, Correnti C, Kalyuzhniy O, Vittal V, Connell MJ, Stevens E, Schroeter A, Chen M, Macpherson S, Serra AM, Adachi Y, Holmes MA, Li Y, Klevit RE, Graham BS, Wyatt RT, Baker D, Strong RK, Crowe JE Jr, Johnson PR, Schief WR.

Nature. 2014 Mar 13;507(7491):201-6. doi: 10.1038/nature12966. Epub 2014 Feb 5.

5.

Application of PBPK modeling to predict human intestinal metabolism of CYP3A substrates - an evaluation and case study using GastroPlus.

Heikkinen AT, Baneyx G, Caruso A, Parrott N.

Eur J Pharm Sci. 2012 Sep 29;47(2):375-86. doi: 10.1016/j.ejps.2012.06.013. Epub 2012 Jul 1.

PMID:
22759901
6.

Use of physiologically based pharmacokinetic modeling for assessment of drug-drug interactions.

Baneyx G, Fukushima Y, Parrott N.

Future Med Chem. 2012 Apr;4(5):681-93. doi: 10.4155/fmc.12.13. Review.

PMID:
22458685
7.

Exploiting fluorescence resonance energy transfer to probe structural changes in a macromolecule during adsorption and incorporation into a growing biomineral crystal.

Touryan LA, Baneyx G, Vogel V.

Colloids Surf B Biointerfaces. 2009 Dec 1;74(2):401-9. doi: 10.1016/j.colsurfb.2009.07.004. Epub 2009 Jul 14.

8.

Fibronectin in aging extracellular matrix fibrils is progressively unfolded by cells and elicits an enhanced rigidity response.

Antia M, Baneyx G, Kubow KE, Vogel V.

Faraday Discuss. 2008;139:229-49; discussion 309-25, 419-20.

9.

SPARC regulates extracellular matrix organization through its modulation of integrin-linked kinase activity.

Barker TH, Baneyx G, Cardó-Vila M, Workman GA, Weaver M, Menon PM, Dedhar S, Rempel SA, Arap W, Pasqualini R, Vogel V, Sage EH.

J Biol Chem. 2005 Oct 28;280(43):36483-93. Epub 2005 Aug 22.

10.

Single molecule fluorescence studies of surface-adsorbed fibronectin.

Antia M, Islas LD, Boness DA, Baneyx G, Vogel V.

Biomaterials. 2006 Feb;27(5):679-90. Epub 2005 Aug 10.

PMID:
16095684
11.

The tissue engineeting puzzle: a molecular perspective.

Vogel V, Baneyx G.

Annu Rev Biomed Eng. 2003;5:441-63. Review.

PMID:
14527318
12.

Fibronectin extension and unfolding within cell matrix fibrils controlled by cytoskeletal tension.

Baneyx G, Baugh L, Vogel V.

Proc Natl Acad Sci U S A. 2002 Apr 16;99(8):5139-43.

13.

Coexisting conformations of fibronectin in cell culture imaged using fluorescence resonance energy transfer.

Baneyx G, Baugh L, Vogel V.

Proc Natl Acad Sci U S A. 2001 Dec 4;98(25):14464-8. Epub 2001 Nov 20.

14.

Structural insights into the mechanical regulation of molecular recognition sites.

Vogel V, Thomas WE, Craig DW, Krammer A, Baneyx G.

Trends Biotechnol. 2001 Oct;19(10):416-23. Review.

PMID:
11587768

Supplemental Content

Loading ...
Support Center